Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning
- PMID: 29715319
- PMCID: PMC5929501
- DOI: 10.1371/journal.pone.0196516
Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning
Erratum in
-
Correction: Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning.PLoS One. 2018 Jun 25;13(6):e0199907. doi: 10.1371/journal.pone.0199907. eCollection 2018. PLoS One. 2018. PMID: 29940029 Free PMC article.
Abstract
This study was aimed to estimate the prevalences of chlamydia (CT) and gonococcal (NG) infections and explore risk factors associated with the CT infection among women in Shenzhen, China. We collected socio-demographic and clinical data from women (aged 20-60) and determined positivity of CT or NG by nucleic acid amplification test (NAAT) with self-collected urine specimens. We estimated prevalence of CT and NG and determined risk factors associated with CT infection. Among 9,207 participants, 4.12% (95% confidence interval [CI], 3.71%-4.53%) tested positive for CT and 0.17% (95% CIs, 0.09%-0.25%) for NG. Factors significantly associated with CT infection included being an ethnic minority (ethnicity other than Han China) (Adjusted odds ratio [AOR], 1.9; 95% CI, 1.2-3.0), using methods other than condom for contraception (AOR, 1.5; 95% CI, 1.2-1.8), having a history of adverse pregnancy outcomes (AOR, 1.4; 95% CI, 1.1-1.8), and experiencing reproductive tract symptoms in the past three months (AOR, 1.3; 95% CI, 1.0-1.7). we found that CT infection is prevalent among women in Shenzhen, China and associated with both demographic and behavioral factors. A comprehensive CT screening, surveillance and treatment programme targeting this population is warranted.
Conflict of interest statement
References
-
- Joseph Davey DL, Shull HI, Billings JD, Wang D, Adachi K, Klausner JD. Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015: A Systematic Review. Sexually transmitted diseases. 2016;43(7):450–8. doi: 10.1097/OLQ.0000000000000460 - DOI - PMC - PubMed
-
- Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015;10(12):e0143304 doi: 10.1371/journal.pone.0143304 - DOI - PMC - PubMed
-
- Center for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2015. Atlanta: U.S. Department of Health and Human Services, 2016.
-
- Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. The Journal of infectious diseases. 2010;201 Suppl 2:S134–55. doi: 10.1086/652395 - DOI - PubMed
-
- Peipert JF. Clinical practice. Genital chlamydial infections. The New England journal of medicine. 2003;349(25):2424–30. doi: 10.1056/NEJMcp030542 - DOI - PubMed